company background image
AFP logo

AFT Pharmaceuticals ASX:AFP Stock Report

Last Price

AU$2.22

Market Cap

AU$254.9m

7D

0.5%

1Y

-32.7%

Updated

25 Nov, 2024

Data

Company Financials +

AFT Pharmaceuticals Limited

ASX:AFP Stock Report

Market Cap: AU$254.9m

AFP Stock Overview

Engages in the development and sale of pharmaceutical products in New Zealand, Australia, Asia, and internationally. More details

AFP fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance2/6
Financial Health6/6
Dividends0/6

Rewards

Trading at 82.9% below our estimate of its fair value

Earnings are forecast to grow 23.57% per year

Earnings have grown 9.7% per year over the past 5 years

Risk Analysis

No risks detected for AFP from our risk checks.

AFT Pharmaceuticals Limited Competitors

Vita Life Sciences

ASX:VLS

AU$117.1m

Vitura Health

ASX:VIT

AU$57.0m

ECS Botanics Holdings

ASX:ECS

AU$21.9m

Neuren Pharmaceuticals

ASX:NEU

AU$1.6b

Price History & Performance

Summary of all time highs, changes and price drops for AFT Pharmaceuticals
Historical stock prices
Current Share PriceNZ$2.22
52 Week HighNZ$3.53
52 Week LowNZ$2.15
Beta0.37
11 Month Change-25.75%
3 Month Change-22.65%
1 Year Change-32.73%
33 Year Change-50.34%
5 Year Change-23.71%
Change since IPO-24.75%

Recent News & Updates

Recent updates

Shareholder Returns

AFPAU PharmaceuticalsAU Market
7D0.5%-16.4%0.9%
1Y-32.7%32.3%18.4%

Return vs Industry: AFP underperformed the Australian Pharmaceuticals industry which returned 32.3% over the past year.

Return vs Market: AFP underperformed the Australian Market which returned 18.4% over the past year.

Price Volatility

Is AFP's price volatile compared to industry and market?
AFP volatility
AFP Average Weekly Movement9.4%
Pharmaceuticals Industry Average Movement11.9%
Market Average Movement8.5%
10% most volatile stocks in AU Market17.5%
10% least volatile stocks in AU Market3.2%

Stable Share Price: AFP has not had significant price volatility in the past 3 months compared to the Australian market.

Volatility Over Time: AFP's weekly volatility (9%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1997110Hartley Atkinsonwww.aftpharm.com

AFT Pharmaceuticals Limited, together with its subsidiaries, engages in the development and sale of pharmaceutical products in New Zealand, Australia, Asia, and internationally. It offers products for use in the areas of allergy, gastrointestinal, cold and flu, digestive health, eye care, first aid, nail care, oral care, pain management, skin care, vitamins, and supplements, as well as other products. AFT Pharmaceuticals Limited was incorporated in 1997 and is headquartered in Auckland, New Zealand.

AFT Pharmaceuticals Limited Fundamentals Summary

How do AFT Pharmaceuticals's earnings and revenue compare to its market cap?
AFP fundamental statistics
Market capAU$254.95m
Earnings (TTM)AU$10.41m
Revenue (TTM)AU$178.08m

24.5x

P/E Ratio

1.4x

P/S Ratio

Is AFP overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
AFP income statement (TTM)
RevenueNZ$198.51m
Cost of RevenueNZ$109.98m
Gross ProfitNZ$88.54m
Other ExpensesNZ$76.93m
EarningsNZ$11.61m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.11
Gross Margin44.60%
Net Profit Margin5.85%
Debt/Equity Ratio36.0%

How did AFP perform over the long term?

See historical performance and comparison

Dividends

0.6%

Current Dividend Yield

16%

Payout Ratio